|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2006-8-21
|
|
pubmed:abstractText |
Carbonic anhydrase 9 recognized by chimeric monoclonal antibody cG250 is overexpressed on biliary cancers. The aim of this study was to determine the targeting of radiolabeled cG250 in patients with biliary cancer to explore a potential role of radioimmunotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1084-9785
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
263-8
|
|
pubmed:dateRevised |
2011-7-29
|
|
pubmed:meshHeading |
pubmed-meshheading:16918303-Antibodies, Monoclonal,
pubmed-meshheading:16918303-Antigens, Neoplasm,
pubmed-meshheading:16918303-Biliary Tract Neoplasms,
pubmed-meshheading:16918303-Carbonic Anhydrases,
pubmed-meshheading:16918303-Female,
pubmed-meshheading:16918303-Humans,
pubmed-meshheading:16918303-Immunohistochemistry,
pubmed-meshheading:16918303-Iodine Radioisotopes,
pubmed-meshheading:16918303-Male,
pubmed-meshheading:16918303-Middle Aged,
pubmed-meshheading:16918303-Quality Control,
pubmed-meshheading:16918303-Radioimmunotherapy,
pubmed-meshheading:16918303-Radionuclide Imaging,
pubmed-meshheading:16918303-Recombinant Fusion Proteins,
pubmed-meshheading:16918303-Time Factors,
pubmed-meshheading:16918303-Tomography, X-Ray Computed
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Targeting of biliary cancer with radiolabeled chimeric monoclonal antibody CG250.
|
|
pubmed:affiliation |
Department of Nuclear Medicine, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands. b.hendrickx@nucmed.umcn.nl
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
